Literature DB >> 34919692

Composition and Stability of the Vaginal Microbiota of Pregnant Women With Inflammatory Bowel Disease.

Janet E Hill1, Juan-Nicolás Peña-Sánchez2, Champika Fernando1, Aline C Freitas1, Niradha Withana Gamage1,3, Sharyle Fowler4.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) is common in women of childbearing years, and active IBD during pregnancy is associated with increased rates of preterm delivery and low-birth-weight newborns. Changes in the vaginal microbiome have been associated with preterm delivery. We aimed to determine the taxonomic composition of the vaginal microbiota at 3 time points during pregnancy in a population of women with IBD.
METHODS: Participants were recruited from the patient registry of the Preconception and Pregnancy IBD Clinic at Royal University Hospital in Saskatoon, Canada. Self-collected vaginal swabs were obtained from patients at each trimester. Microbiota profiles were created by cpn60 amplicon sequencing.
RESULTS: We characterized the vaginal microbiota of 32 pregnant participants with IBD (33 pregnancies) during each trimester. A total of 32 of 33 pregnancies resulted in a live birth with 43.8% (n = 14 of 32, 2 missing) by caesarean section; 2 of 32 were preterm. Microbiota compositions corresponded to previously described community state types, with most participants having microbiota dominated by Lactobacillus crispatus. In 25 of 29 participants in which samples were available for more than 1 time point, there was no change in the community state type over time. Prevalence of Mollicutes (Mycoplasma and/or Ureaplasma) was significantly higher in pregnant participants with IBD than in a previously profiled cohort of 172 pregnant women without IBD who delivered at term.
CONCLUSIONS: The vaginal microbiome of participants with IBD was stable throughout pregnancy. Prevalence of Mollicutes, which has been associated with preterm delivery, warrants further study in this patient group.
© 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation.

Entities:  

Keywords:  Inflammatory bowel diseases; Microbiota; Mollicutes; Pregnancy; Vagina

Mesh:

Substances:

Year:  2022        PMID: 34919692      PMCID: PMC9165555          DOI: 10.1093/ibd/izab314

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   7.290


  44 in total

1.  Crohn's disease as a risk factor for the outcome of pregnancy.

Authors:  M Morales; T Berney; A Jenny; P Morel; P Extermann
Journal:  Hepatogastroenterology       Date:  2000 Nov-Dec

2.  Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries.

Authors:  K Fonager; H T Sørensen; J Olsen; J F Dahlerup; S N Rasmussen
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

Review 3.  Microbiome and immunological interactions.

Authors:  Denise Kelly; Imke E Mulder
Journal:  Nutr Rev       Date:  2012-08       Impact factor: 7.110

4.  Perianal Crohn's disease and pregnancy: role of the mode of delivery.

Authors:  A Ilnyckyji; J F Blanchard; P Rawsthorne; C N Bernstein
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

5.  Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study.

Authors:  Bente Nørgård; Heidi H Hundborg; Bent A Jacobsen; Gunnar L Nielsen; Kirsten Fonager
Journal:  Am J Gastroenterol       Date:  2007-06-15       Impact factor: 10.864

6.  Pyrosequencing of the chaperonin-60 universal target as a tool for determining microbial community composition.

Authors:  John Schellenberg; Matthew G Links; Janet E Hill; Tim J Dumonceaux; Geoffrey A Peters; Shaun Tyler; T Blake Ball; Alberto Severini; Francis A Plummer
Journal:  Appl Environ Microbiol       Date:  2009-03-06       Impact factor: 4.792

7.  Multiplex detection of bacteria associated with normal microbiota and with bacterial vaginosis in vaginal swabs by use of oligonucleotide-coupled fluorescent microspheres.

Authors:  Tim J Dumonceaux; John Schellenberg; Vanessa Goleski; Janet E Hill; Walter Jaoko; Joshua Kimani; Deborah Money; T Blake Ball; Francis A Plummer; Alberto Severini
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

8.  Differences in vaginal microbiome in African American women versus women of European ancestry.

Authors:  Jennifer M Fettweis; J Paul Brooks; Myrna G Serrano; Nihar U Sheth; Philippe H Girerd; David J Edwards; Jerome F Strauss; Kimberly K Jefferson; Gregory A Buck
Journal:  Microbiology (Reading)       Date:  2014-07-29       Impact factor: 2.777

9.  A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy.

Authors:  Kjersti Aagaard; Kevin Riehle; Jun Ma; Nicola Segata; Toni-Ann Mistretta; Cristian Coarfa; Sabeen Raza; Sean Rosenbaum; Ignatia Van den Veyver; Aleksandar Milosavljevic; Dirk Gevers; Curtis Huttenhower; Joseph Petrosino; James Versalovic
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

10.  Vaginal microbiota in pregnant women with inflammatory rheumatic and inflammatory bowel disease: A matched case-control study.

Authors:  Klara Rosta; Antonia Mazzucato-Puchner; Herbert Kiss; Veronika Malik; Peter Mandl; Ljubomir Petricevic; Philipp Foessleitner; Inbal Shafran; Wilhelm Temsch; Alex Farr
Journal:  Mycoses       Date:  2021-04-22       Impact factor: 4.377

View more
  1 in total

Review 1.  A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances.

Authors:  Maheeba Abdulla; Nafeesa Mohammed
Journal:  Biologics       Date:  2022-09-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.